Atom Investors LP Sells 17,101 Shares of The Allstate Co. (NYSE:ALL)

Atom Investors LP decreased its holdings in The Allstate Co. (NYSE:ALL) by 33.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,301 shares of the insurance provider’s stock after selling 17,101 shares during the quarter. Atom Investors LP’s holdings in Allstate were worth $6,505,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. SPC Financial Inc. lifted its stake in Allstate by 3.6% during the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock valued at $297,000 after acquiring an additional 54 shares in the last quarter. Lake Street Advisors Group LLC grew its holdings in shares of Allstate by 1.8% in the third quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock valued at $596,000 after acquiring an additional 54 shares in the last quarter. Abacus Planning Group Inc. increased its holdings in Allstate by 2.4% during the third quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock worth $458,000 after buying an additional 56 shares during the last quarter. Chicago Partners Investment Group LLC raised its stake in shares of Allstate by 1.3% in the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after buying an additional 59 shares during the period. Finally, Carmichael Hill & Associates Inc. raised its position in shares of Allstate by 15.0% in the third quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. TD Cowen upped their target price on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. Evercore ISI boosted their price objective on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a report on Wednesday, October 9th. Barclays raised their price objective on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday, October 31st. Roth Mkm reaffirmed a “buy” rating and set a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and an average target price of $217.19.

Allstate Trading Down 0.4 %

NYSE ALL opened at $207.39 on Monday. The firm has a market cap of $54.92 billion, a PE ratio of 13.43, a price-to-earnings-growth ratio of 1.82 and a beta of 0.48. The Allstate Co. has a 52 week low of $134.17 and a 52 week high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The company has a 50 day moving average price of $193.02 and a 200 day moving average price of $179.19.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter last year, the firm earned $0.81 EPS. The business’s quarterly revenue was up 14.7% on a year-over-year basis. As a group, sell-side analysts forecast that The Allstate Co. will post 16.26 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Friday, November 29th. Allstate’s payout ratio is 23.83%.

Insider Buying and Selling

In related news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 57.06 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.80% of the stock is currently owned by company insiders.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.